NCT01451294

Brief Summary

Carotid endarterectomy (CEA) is the recommended treatment for symptomatic high degree stenosis of the internal carotid artery (ICA). ICA obstruction is often associated with an impaired cerebral autoregulation, implicating that cerebral perfusion pressure becomes dependent on systemic blood pressure. Therefore, to maintain cerebral perfusion pressure in this type of patients intraoperative hypotension needs to be avoided. Different short-acting agents such as phenylephrine, (a drug with vasoconstrictive properties), or ephedrine (a drug with vasoconstrictive properties combined with an increase in heart rate) can be used to correct intra-operative hypotension. In healthy subjects these agents affect the cerebral perfusion differently despite an identical effect on the systemic blood pressure. Cerebral perfusion decreases after phenylephrine administration while it is preserved after the use of ephedrine. The optimal agent for correcting hypotension in CEA patients, and thus in a situation of an impaired cerebral autoregulation, is unknown. Therefore, the investigators propose to perform a prospective study observing the effect of phenylephrine and ephedrine on cerebral perfusion to make a recommendation regarding the use of either phenylephrine or ephedrine during CEA.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2011

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 22, 2011

Completed
21 days until next milestone

First Posted

Study publicly available on registry

October 13, 2011

Completed
19 days until next milestone

Study Start

First participant enrolled

November 1, 2011

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2012

Completed
Last Updated

October 13, 2011

Status Verified

October 1, 2011

Enrollment Period

4 months

First QC Date

September 22, 2011

Last Update Submit

October 12, 2011

Conditions

Keywords

Cerebral autoregulation

Outcome Measures

Primary Outcomes (1)

  • cerebral perfusion (rSO2) measured using Near Infrared Spectroscopy

    A continuous measurement during surgery will be performed. However for further analysis only a short time frame will be used.

    (day 1) Monitoring will take place only on the day of operation. No further follow-up. Timeframe is 1 day.

Secondary Outcomes (1)

  • Blood velocity (Vmca) measured using transcranial Doppler

    Within 18 months in consecutive patients undergoing carotid endarterectomy. Endpoints will only be assessed during actual surgery (approximately 90 minutes in total) no data will be assessed during follow-up.

Study Arms (2)

Ephedrine

ACTIVE COMPARATOR
Drug: Administration of ephedrine

Phenylephrine

ACTIVE COMPARATOR
Drug: Administration of phenylephrine

Interventions

Phenylephrine: 50-100µg

Phenylephrine

Ephedrine: 5- 10 mg

Ephedrine

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All patients undergoing CEA in the University Medical Centre Utrecht and having an appropriate temporal bone window for reliable perioperative TCD monitoring could be included.
  • All patients must have given written informed consent.

You may not qualify if:

  • Not having a temporal bone window appropriate for TCD measurement
  • Not willing to give informed consent.
  • If the effect on BP of the given agents is insufficient (if relative hypotension persists five minutes after administration).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Center Utrecht

Utrecht, Utrecht, 3584 CX, Netherlands

Location

Related Publications (4)

  • Nissen P, Brassard P, Jorgensen TB, Secher NH. Phenylephrine but not ephedrine reduces frontal lobe oxygenation following anesthesia-induced hypotension. Neurocrit Care. 2010 Feb;12(1):17-23. doi: 10.1007/s12028-009-9313-x.

    PMID: 19957053BACKGROUND
  • Fassaert LMM, de Borst GJ, Pennekamp CWA, Specken-Welleweerd JC, Moll FL, van Klei WA, Immink RV. Effect of Phenylephrine and Ephedrine on Cerebral (Tissue) Oxygen Saturation During Carotid Endarterectomy (PEPPER): A Randomized Controlled Trial. Neurocrit Care. 2019 Dec;31(3):514-525. doi: 10.1007/s12028-019-00749-w.

  • Heusdens JF, Lof S, Pennekamp CW, Specken-Welleweerd JC, de Borst GJ, van Klei WA, van Wolfswinkel L, Immink RV. Validation of non-invasive arterial pressure monitoring during carotid endarterectomy. Br J Anaesth. 2016 Sep;117(3):316-23. doi: 10.1093/bja/aew268.

  • Pennekamp CW, Immink RV, Buhre WF, Moll FL, de Borst GJ. Phenylephrine versus ephedrine on cerebral perfusion during carotid endarterectomy (PEPPER): study protocol for a randomized controlled trial. Trials. 2013 Feb 14;14:43. doi: 10.1186/1745-6215-14-43.

MeSH Terms

Conditions

Carotid Stenosis

Condition Hierarchy (Ancestors)

Carotid Artery DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Gert Jan de Borst, MD, PhD

    UMC Utrecht, The Netherlands

    STUDY DIRECTOR
  • Claire Pennekamp, MD

    UMC Utrecht, The Netherlands

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gert Jan de Borst, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Vascular surgeon; Head of cerebrovascular surgical programme.

Study Record Dates

First Submitted

September 22, 2011

First Posted

October 13, 2011

Study Start

November 1, 2011

Primary Completion

March 1, 2012

Study Completion

March 1, 2012

Last Updated

October 13, 2011

Record last verified: 2011-10

Locations